Antonio Giovanni Richetta | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Efficacy and safety of tildrakizumab in elderly patients. Real-world multicenter study (ESTER - study)	JOURNAL OF DERMATOLOGICAL TREATMENT	2024
Expression Analysis of Circulating microRNAs in Saliva and Plasma for the Identification of Clinically Relevant Biomarkers for Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.	CANCERS	2024
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)	FRONTIERS IN MEDICINE	2023
A multidisciplinary approach for patients with moderate-to-severe psoriasis: an advisable network of management	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement	JOURNAL OF CLINICAL MEDICINE	2023
Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration	JOURNAL OF CLINICAL MEDICINE	2023
Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent. Case report and review of literature	THE ITALIAN JOURNAL OF PEDIATRICS	2022
Risankizumab for the treatment of moderate-to-severe psoriasis. A multicenter, retrospective, 1 year real-life study	DERMATOLOGIC THERAPY	2022
A possible link between gut microbiome composition and cardiovascular comorbidities in psoriatic patients	JOURNAL OF PERSONALIZED MEDICINE	2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year	EXPERT OPINION ON BIOLOGICAL THERAPY	2022
Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy	JOURNAL OF DERMATOLOGY	2021
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: a case report	AUSTRALASIAN JOURNAL OF DERMATOLOGY	2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy	EXPERT OPINION ON BIOLOGICAL THERAPY	2021
Increased intestinal barrier permeability in patients with moderate to severe plaque-type psoriasis	JOURNAL OF DERMATOLOGY	2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY	2020
Paradoxical psoriasis induced by Anti-TNFα treatment: Evaluation of disease-specific clinical and genetic markers	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020
Serum tryptase levels in melanoma patients: case-control study and review of the literature	GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA	2019
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.	ANTICANCER RESEARCH	2019
The barrier beyond the skin	GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA	2019